Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against <i>Aspergillus</i><i>fumigatus</i> and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values

• Main Authors: Marcia S. C. Melhem (Author), Vivian C. Coelho (Author), Claudia A. Fonseca (Author), Lidiane de Oliveira (Author), Lucas X. Bonfietti (Author), Maria. W. Szeszs (Author), Marcello M. C. Magri (Author), Francine S. Dorneles (Author), Hideaki Taguchi (Author), Daniel V. S. Moreira (Author), Adriana L. Motta (Author), Marjorie V. Batista (Author), Katsuhiko Kamei (Author), Maria A. Shikanai-Yasuda (Author)
• Format: Book
• Published: MDPI AG, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aspergillosis is an invasive fungal disease associated with high mortality. Antifungal susceptibility testing (AFST) is receiving increasing consideration for managing patients, as well as for surveilling emerging drug resistance, despite having time-consuming and technically complex reference metho...